XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.glycosmedia.com/pre-eclampsia-hypertension-severe-diabetic-retinopathy-2/20%Monthly2015-01-19 16:34
https://www.glycosmedia.com/easd-barcelona-2013/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/advice-for-people-newly-diagnosed-with-type-2-diabetes/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/novo-nordisks-diabetes-combination-ideglira-impresses-in-study/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/ldp-cardiovascular-outcomes-in-t2d/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/new-data-for-novartis-drug-lucentis/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/health-minister-launches-diabetes-delivery-plan/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/antidepressant-medication-as-a-risk-factor-for-t2d-2/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/dextrose-gel-for-neonatal-hypoglycaemia/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/effects-of-adding-linagliptin-to-basal-insulin-t2d/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/type-2-diabetes-lixisenatide/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/diabetes-treatments-and-cancer-risk-drug-exposure/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/takeda-european-marketing-authorization-for-3-t2d-therapies/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/post-hoc-analyses-safety-profile-of-linagliptin-t2d/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/dietary-patterns-and-type-2-diabetes/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/gliptins-goodish-news/20%Monthly2015-01-15 02:54
https://www.glycosmedia.com/urinary-orosomucoid-predicts-cardiovascular-mortality-t2d/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/targeting-of-memory-t-cells-with-alefacept-in-new-onset-t1d-2/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/cardiac-implications-of-hypoglycaemia/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/novo-nordisk-replies-to-bmj-investigation-on-incretins-and-pancreatic-damage/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/transplantation-the-cit07-protocol-cell-secretory-capacity-2/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/new-facility-to-produce-a-solid-dose-medication-for-t2d/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/culturally-sensitive-patient-centred-education-for-t2d/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/2-aminoadipic-acid-is-a-biomarker-for-diabetes-risk/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/postmenopausal-cardiovascular-cancer-mortality-rates-usa/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/experience-of-older-women-living-and-with-coping-t2d-2/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/changes-in-time-to-insulin-initiation-in-type-2-diabetes-patients-2/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/intensity-of-peri-operative-glycemic-control-outcomes/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/time-lag-of-glucose-from-intravascular-to-interstitial-compartment/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/depression-and-death-in-diabetes/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/early-diabetic-nephropathy-a-complication-of-reduced-is/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/diabetes-drug-reverses-alzheimers-could-be-available-5-years/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/linagliptin-lowers-albuminuria-in-t2d-renal-dysfunction/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/network-level-structural-abnormalities-of-cerebral-cortex-t1d/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/long-term-metabolic-effects-bariatric-surgery-t2d/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/basal-insulin-analogues-what-progress-have-we-made/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/efficacy-subcutaneous-acth-gel-on-proteinuria-progression-of-ckd/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/sanofi-provides-update-on-lixisenatide-nda-in-u-s/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/2nd-line-therapy-vildagliptin-v-oral-agents-t2d/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/prostate-volume-correlates-with-diabetes-in-bph/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/type-2-diabetes-insulin-degludec/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/type-1-diabetes-insulin-degludec/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/cognitive-impairment-associated-with-metformin/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/preadmission-metformin-mortality-in-intensive-care/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/islet-autoimmunity-in-phenotypic-t2d/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/amino-acid-with-promising-anti-diabetic-effects/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/lixisenatide-lyxumia-is-accepted-for-restricted-use-within-nhs-scotland/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/bid-success-could-change-the-face-of-paediatric-diabetes-healthcare-2/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/early-treatment-regimen-impact-on-cell-preservation-t2d-2/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/empagliflozin-monotherapy-with-sitagliptin-in-t2d/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/sglt2-versus-dpp4-inhibitors-for-type-2-diabetes-2/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/fasting-glucose-nocturnal-hypoglycemia-in-elderly-male-t2d-2/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/incretin-drugs-and-pancreas-safety/20%Monthly2015-01-15 02:55
https://www.glycosmedia.com/lifetime-direct-medical-costs-of-treating-t2d-complications-2/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/prevalence-and-control-of-diabetes-in-the-chinese-population/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/feedback-retinal-images-motivational-impact-with-non-proliferative-dr/20%Monthly2015-01-19 16:34
https://www.glycosmedia.com/the-cardiovascular-safety-of-diabetes-drugs/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/alogliptin-after-acute-coronary-syndrome-t2d/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/saxagliptin-and-cardiovascular-outcomes-t2d/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/onglyza-no-increased-risk-for-cardiovascular-death-savor-trial-2/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/albuminuria-and-cognitive-decline-2/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/insulin-resistance-and-bone-strength-2/20%Monthly2015-01-19 15:40
https://www.glycosmedia.com/cost-effectiveness-of-dose-adjustment-for-normal-eating-dafne/20%Monthly2015-01-19 15:40